Literature DB >> 16778198

Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.

Yuichiro Maruyama1, Mayumi Ono, Akihiko Kawahara, Toshiro Yokoyama, Yuji Basaki, Masayoshi Kage, Shigeaki Aoyagi, Hisafumi Kinoshita, Michihiko Kuwano.   

Abstract

Cap43 has been identified as a nickel- and calcium-induced gene, and is also known as N-myc downstream-regulated gene 1 (NDRG1), Drg-1 and rit42. It is also reported that overexpression of Cap43 suppresses metastasis of some malignancies, but its precise role remains unclear. In this study, we asked how Cap43 could modulate the tumor growth of pancreatic cancer. Stable Cap43 cDNA transfectants of pancreatic cancer cells with Cap43 overexpression showed similar growth rates in culture as their control counterparts with low Cap43 protein level. By contrast, Cap43 overexpression showed a marked decrease in tumor growth rates in vivo. Moreover, a marked reduction in tumor-induced angiogenesis was observed. Gelatinolytic activity by matrix metalloproteinase-9 and invasive ability in Matrigel invasion activity were markedly decreased in pancreatic cancer cell lines with high Cap43 expression. Cellular expression of matrix metalloproteinase-9 and two major angiogenic factors, vascular endothelial growth factor and interleukin-8, were also significantly decreased in cell lines with Cap43 overexpression as compared with their parental counterparts. Immunohistochemical analysis of specimens from 65 patients with pancreatic ductal adenocarcinoma showed a significant association between Cap43 expression and tumor microvascular density (P = 0.0001) as well as depth of invasion (P = 0.0003), histopathologic grading (P = 0.0244), and overall survival rates for patients with pancreatic cancer (P = 0.0062). Thus, Cap43 could play a key role in the angiogenic on- or off-switch of tumor stroma in pancreatic ductal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778198     DOI: 10.1158/0008-5472.CAN-06-0183

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Expression and biological function of N-myc down-regulated gene 1 in human cervical cancer.

Authors:  Jing Wang; Jing Cai; Zhimin Li; Sha Hu; Lili Yu; Lan Xiao; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

2.  The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.

Authors:  Sharleen V Menezes; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

3.  Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2.

Authors:  Yan-Li Liu; Wen-Tao Bai; Wen Luo; De-Xin Zhang; Yan Yan; Zhi-Kai Xu; Fang-Lin Zhang
Journal:  Tumour Biol       Date:  2010-10-30

4.  NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.

Authors:  Xiaojing Chang; Xiaoyang Xu; Xiaoying Xue; Jinguo Ma; Zhenhua Li; Peng Deng; Jing Chen; Shuanglong Zhang; Yu Zhi; Dongqiu Dai
Journal:  Pathol Oncol Res       Date:  2016-05-06       Impact factor: 3.201

5.  Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer.

Authors:  Akihiko Kawahara; Jun Akiba; Satoshi Hattori; Tomohiko Yamaguchi; Hideyuki Abe; Tomoki Taira; Hiroki Ureshino; Yuichi Murakami; Kosuke Watari; Kikuo Koufuji; Kazuo Shirouzu; Michihiko Kuwano; Mayumi Ono; Masayoshi Kage
Journal:  Exp Ther Med       Date:  2011-03-02       Impact factor: 2.447

6.  Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients.

Authors:  Kohei Matsushita; Keiichi Uchida; Susumu Saigusa; Shozo Ide; Kiyoshi Hashimoto; Yuhki Koike; Kohei Otake; Mikihiro Inoue; Koji Tanaka; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2013-04       Impact factor: 1.827

7.  NDRG1 prognosticates the natural course of disease in WHO grade II glioma.

Authors:  J Blaes; M Weiler; F Sahm; B Hentschel; M Osswald; M Czabanka; C M Thomé; M G Schliesser; S Pusch; S Luger; F Winkler; A Radbruch; M Jugold; M Simon; J P Steinbach; G Schackert; M Tatagiba; M Westphal; J C Tonn; D Gramatzki; T Pietsch; C Hartmann; H Glimm; P Vajkoczy; A von Deimling; M Platten; M Weller; W Wick
Journal:  J Neurooncol       Date:  2014-01-07       Impact factor: 4.130

8.  Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.

Authors:  Graham Dominick; Darlene E Berryman; Edward O List; John J Kopchick; Xinna Li; Richard A Miller; Gonzalo G Garcia
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

9.  N-myc downstream-regulated gene 1 (NDRG1) a differentiation marker of human breast cancer.

Authors:  Abbas Fotovati; Samah Abu-Ali; Masayoshi Kage; Kazuo Shirouzu; Hideaki Yamana; Michihiko Kuwano
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

10.  NDRG1 protein overexpression in malignant thyroid neoplasms.

Authors:  Renê Gerhard; Suely Nonogaki; José Humberto Tavares Guerreiro Fregnani; Fernando Augusto Soares; Maria Aparecida Nagai
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.